Danish Publicly-traded, Biopharma Company with EU-GACP/GMP facility & strong market position

A fully licensed manufacturing site

Holds both EU-GMP and EU-GACP in an totally indoor, leased, 1,200 m2 state-of-the-art production facility utilizing aeroponics-technology and vertical farming located in an industrial area – introducing some of the cleanest world-wide (non-irradiated) flower material to the European market

Currently operational and currently utilizing 400 m2production space and 200 m2 for administration and office space

Perfect fit for repurposing i.e. facility for import into the European market – due to the 100% indoor facility with EU-GMP approval and fully operational QMS

Currently undertaking, cultivation, propagation trimming, drying, bulk packaging, labelling, finished packaging, exports, storage, distribution and export

Current production capacity is ~100 kg year/strain and capable to upscale the capacity to produce ~2,200 kg/year of dried cannabis (based on 1-6 strains)

At current scale (cultivation), the company expects to hit €270k/yearly (2 MDKK/yearly) and at full commercial scale, it is expected to generate €6.7 million/yearly (50 MDKK/yearly)

There is an expansion of 600 m2 possibility to build other production rooms to increase the production capacity to ~2,200 kg/year in the same industrial area – resulting in a highly efficient utilization of square meters

Long term lease (10-years rental agreement)

More than €7 million spent in the facility

Facility comes with all supporting fixtures and equipment

Company is seeking buyer for the turnkey project

There is an option to acquire the building within the tenor of the rental agreement (real estate valued at ~€910k)